PT1800664E - Formulações farmacêuticas para administração parentérica compreendendo epotilona - Google Patents

Formulações farmacêuticas para administração parentérica compreendendo epotilona Download PDF

Info

Publication number
PT1800664E
PT1800664E PT07102856T PT07102856T PT1800664E PT 1800664 E PT1800664 E PT 1800664E PT 07102856 T PT07102856 T PT 07102856T PT 07102856 T PT07102856 T PT 07102856T PT 1800664 E PT1800664 E PT 1800664E
Authority
PT
Portugal
Prior art keywords
epothilone
pharmaceutical formulations
parenteral administration
administration
methods
Prior art date
Application number
PT07102856T
Other languages
English (en)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1800664(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1800664E publication Critical patent/PT1800664E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT07102856T 1998-02-05 1999-02-03 Formulações farmacêuticas para administração parentérica compreendendo epotilona PT1800664E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds

Publications (1)

Publication Number Publication Date
PT1800664E true PT1800664E (pt) 2009-07-10

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07102856T PT1800664E (pt) 1998-02-05 1999-02-03 Formulações farmacêuticas para administração parentérica compreendendo epotilona

Country Status (9)

Country Link
EP (1) EP1800664B8 (pt)
AT (1) ATE427736T1 (pt)
CY (1) CY1109190T1 (pt)
DE (1) DE69940708D1 (pt)
DK (1) DK1800664T3 (pt)
ES (1) ES2324376T3 (pt)
GB (1) GB9802451D0 (pt)
PT (1) PT1800664E (pt)
ZA (1) ZA99874B (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
DK1186606T4 (da) * 1995-11-17 2011-12-05 Biotechnolog Forschung Gmbh Epothilonderivater, deres fremstilling og anvendelse
DE69735057T2 (de) * 1996-03-12 2006-08-31 PG-TXL Co., L.P., Houston Wasserlösliche paclitaxel-prodrogen
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
SK287775B6 (sk) * 1998-02-05 2011-09-05 Novartis Ag Farmaceutická formulácia obsahujúca epothilon, infúzny roztok a použitie farmaceutickej formulácie

Also Published As

Publication number Publication date
CY1109190T1 (el) 2014-07-02
GB9802451D0 (en) 1998-04-01
DE69940708D1 (de) 2009-05-20
EP1800664A1 (en) 2007-06-27
DK1800664T3 (da) 2009-07-20
ZA99874B (en) 1999-08-05
ES2324376T3 (es) 2009-08-05
EP1800664B8 (en) 2010-12-15
EP1800664B1 (en) 2009-04-08
ATE427736T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
AU3068599A (en) Medication infusion set
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
WO2000007979A3 (en) Compounds and compositions for delivering active agents
EP0993831A3 (en) Compounds and compositions for delivering active agents
TW355683B (en) Composition containing micronized nebivolol
NZ508249A (en) Use of PEG-IFN-alpha conjugates in association with ribavirin for the treatment of chronic hepatitis C
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
CA2338358A1 (en) Compounds and compositions for delivering active agents
IL136512A0 (en) Intravenous infusion administration set
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
WO2000003724A1 (en) Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
WO1997026918A3 (en) Ligand directed enzyme prodrug therapy
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU6924298A (en) 2,3-dihydrofuro{3,2-(b)}pyridin, preparation and application thereof in therapy
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
PT1800664E (pt) Formulações farmacêuticas para administração parentérica compreendendo epotilona
AU6408400A (en) Tapered intravenous cannula
IL139863A0 (en) 3,4-diphenyl bicyclo [4.3.0] nonyl derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof